SEC 13F Intelligence

Nitorum Capital, L.P. / UTH

Nitorum Capital, L.P.’s United Therapeutics Corp Del Position

Does Nitorum Capital, L.P. own United Therapeutics Corp Del (UTH)? Yes — 11.5K shares worth $7M (+5.97% of its 13F portfolio) as of Q1 2026, down from 37.0K shares the prior filed quarter.

Position Value
$7M
Q1 2026
Shares
11.5K
% of Portfolio
+5.97%
Quarters Held
11
currently held

Position History UTH

Reported value by quarter
Q3 ’23: $25MQ3 ’23Q4 ’23: $27MQ1 ’24: $33MQ1 ’24Q2 ’24: $45MQ3 ’24: $41MQ3 ’24Q4 ’24: $34MQ1 ’25: $24MQ1 ’25Q2 ’25: $19MQ3 ’25: $18MQ3 ’25Q4 ’25: $18MQ1 ’26: $7MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202611.5K$7M+5.97%
Q4 202537.0K$18M+3.99%
Q3 202543.4K$18M+3.20%
Q2 202567.5K$19M+2.88%
Q1 202578.0K$24M+3.38%
Q4 202495.4K$34M+3.87%
Q3 2024113.3K$41M+4.09%
Q2 2024140.8K$45M+4.89%
Q1 2024144.9K$33M+3.39%
Q4 2023121.8K$27M+2.87%
Q3 2023111.7K$25M+2.76%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nitorum Capital, L.P.’s full portfolio or all institutional holders of UTH.